
Quarterly Result14 Feb 2026, 09:32 pm
Kimia Biosciences Ltd Announces Q3 and Q4 Results for 2025, Re-Appoints Managing Director, and Approves Postal Ballot Notice
AI Summary
Kimia Biosciences Ltd has announced its financial results for the quarter and nine months ended on 31st December 2025. The company's revenue from operations stands at 3,010.06 lakhs for the quarter and 8,067.70 lakhs for the nine months ended on 31st December 2025. The Board has approved the re-appointment of Mr. Sameer Goel as Managing Director for a further period of five years. A postal ballot notice has been approved to seek approval from shareholders for the regularisation of Mr. Kaku Vijaya Shekhar Reddy as Whole time Director and the re-appointment of Mr. Sameer Goel as Managing Director.
Key Highlights
- Kimia Biosciences Ltd announces Q3 and Q4 results for 2025
- Revenue from operations stands at 3,010.06 lakhs for the quarter
- Board approves re-appointment of Mr. Sameer Goel as Managing Director
- Postal ballot notice approved for shareholder approval
- Regularisation of Mr. Kaku Vijaya Shekhar Reddy as Whole time Director
Price Impact
More from KIMIABL